A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...

Dr. Jeff Watson, with Dynamic Spine and Neuropathy in Sioux Falls, is a leading expert in the field of chiropractics. He recently released a groundbreaking new book titled “A Patient’s ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...

The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...